Delivery Order SPE2DB20D1109-SPE2DB23FN00V
- Not listed
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $5,578.88 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,348.88 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which enables the company to efficiently supply a wide range of...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,353.34 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mls to the Defense Logistics Agency (DLA). The $1,385.37 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mLs pharmaceutical products to the Defense Logistics Agency (DLA). The $3,523.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of November 15, 2023 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- The federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mL injections to the Defense Logistics Agency (DLA). The contract, valued at $7,641.00, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract has a fixed-price,...
- This federal contract award is for the delivery of Humira (CF) Pen 40mg/0.4mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,508.08 contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award is for the supply of Humira (CF) Pen 40 mg/0.4 ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,046.64 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. The IDC is a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This federal contract award is for the delivery of Humira (CF) Pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,124.61 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, held by Cencora, Inc. with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN00VDelivery Order
The federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,046.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 11/14/22 |